In the study by Chen et al., no association was found between PPAR-γ2 Pro12Ala substitution and NAFLD, and no significant difference was observed between this polymorphism and physiological variables [2]. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.